Related Experiment Video
Updated: Jun 24, 2025

Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum
Published on: May 3, 2024
The role of pyroptosis in metabolism and metabolic disease
Zhuyuan Zheng1, Shaojie Yang1, Wanlin Dai2
1Biliary Surgery (2nd General) Unit, Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, PR China.
Abstract:
Pyroptosis is a lytic and pro-inflammatory form of regulated cell death characterized by the formation of membrane pores mediated by the gasdermin protein family. Two main activation pathways have been documented: the caspase-1-dependent canonical pathway and the caspase-4/5/11-dependent noncanonical pathway. Pyroptosis leads to cell swelling, lysis, and the subsequent release of inflammatory mediators, including interleukin-1β (IL-1β) and interleukin-18 (IL-18). Chronic inflammation is a well-established foundation and driver for the development of metabolic diseases. Conversely, metabolic pathway dysregulation can also induce cellular pyroptosis. Recent studies have highlighted the significant role of pyroptosis modulation in various metabolic diseases, including type 2 diabetes mellitus, obesity, and metabolic (dysfunction) associated fatty liver disease. These findings suggest that pyroptosis may serve as a promising novel therapeutic target for metabolic diseases. This paper reviews an in-depth study of the current advancements in understanding the role of pyroptosis in the progression of metabolic diseases.
Insights
Pyroptosis, a cell death process, drives inflammation and metabolic diseases like diabetes and obesity. Targeting pyroptosis offers a new therapeutic strategy for these conditions.
Area of Science:
- Cellular Biology
- Immunology
- Metabolic Disease Research
Background:
- Pyroptosis is a lytic, pro-inflammatory programmed cell death pathway.
- It involves gasdermin proteins forming membrane pores, releasing inflammatory cytokines like IL-1β and IL-18.
- Both canonical (caspase-1) and noncanonical (caspase-4/5/11) pathways activate pyroptosis.
Purpose of the Study:
- To review advancements in understanding pyroptosis's role in metabolic diseases.
- To explore pyroptosis as a potential therapeutic target for metabolic dysfunction.
Main Methods:
- Literature review of current research on pyroptosis and metabolic diseases.
- Analysis of the interplay between metabolic pathways and pyroptosis induction.
- Examination of pyroptosis modulation in type 2 diabetes mellitus, obesity, and metabolic (dysfunction) associated fatty liver disease.
Main Results:
- Chronic inflammation, driven by pyroptosis, contributes to metabolic disease development.
- Dysregulation of metabolic pathways can trigger pyroptosis.
- Pyroptosis plays a significant role in the progression of major metabolic diseases.
Conclusions:
- Pyroptosis is intricately linked to the pathogenesis of metabolic diseases.
- Modulating pyroptosis presents a promising therapeutic avenue for treating metabolic conditions.
- Further research into pyroptosis mechanisms could unlock novel treatment strategies.
Related Concept Videos
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Inborn Errors of Metabolism
Apoptosis
Regulation of Metabolism
Peroxisomes

